Real-time enrollment status for this ulcerative colitis (uc) clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 6:29 AM UTC
| NCT Number | NCT07686081 |
| Recruiting Status | Recruiting |
| Condition | Ulcerative Colitis (UC) |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | August 18, 2026 (Aug 18, 2026) |
As of October 14, 2026: Clinical trial NCT07686081 is currently recruiting participants. This phase3 study for ulcerative colitis (uc) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07686081 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07686081 was last updated Aug 18, 2026 (August 18, 2026). HelloStudys verifies this status automatically.